Share Buyback in H. Lundbeck A/S


                        
Acting on its authorization to acquire up to 10% of its shares the H.
Lundbeck Supervisory Board has resolved to initiate a share buyback
program. Under the program H. Lundbeck will buy own shares for an
amount of up to DKK 6 billion, cf. stock exchange announcement number
166 on 17th August 2005.

During any one single trading day a maximum of 25% of the average
daily trading volume of Lundbeck shares on the Copenhagen Stock
Exchange, calculated over 20 days prior to each trading date, will be
bought back, as the share buyback program is implemented in
accordance with the provisions of the European Commission's
regulation no. 2273/2003 of December 22, 2003.

At least once every seven trading days, Lundbeck will issue an
announcement in respect of the transactions made under the program.

The following transactions have been made under the program:


                       No. of shares        Average Transaction value
                                     purchase price             (DKK)
                                              (DKK)
Accumulated, last         21,191,621       135.1031     2,863,054,619
announcement
3 August 2007          4.029               141,1519        568.701,10
6 August 2007                107.916       138,9107     14.990.690,88
7 August 2007                108.933       137,1711     14.942.456,11
8 August 2007                 83.148       133,8853     11.132.296,96
9 August 2007                112.522       131,6106     14.809.093,27
10 August 2007               125.804       128,1538     16.122.255,32
13 August 2007                    --             --                --
Accumulated under the     21.733.973       135,1108     2.935.620.113
program




Following the above buyback it is hereby announced that Lundbeck owns
a total of 2,451,382 own shares at a nominal value of DKK 5, equal to
1.19% of the total number of 206,870,629 shares.

The content of this release will have no influence on the Lundbeck
Group's financial result for 2007.

Lundbeck contacts


Investors:                  Media:

Jacob Tolstrup              Caroline Broge
Investor Relations Manager, Media Relations Manager
North America               +45 36 43 26 38
+1 201 350 0187


                      ________________________

Stock Exchange Release No 283 - 13 August 2007

About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of drugs
for the treatment of psychiatric and neurological disorders. In 2006,
the company's revenue was DKK 9.2 billion (approximately EUR 1.2
billion or USD 1.6 billion). The number of employees is approximately
5,300 globally. For further information, please visit
www.lundbeck.com

Subscribe